Regenerative Medicine Market: Current Analysis and Forecast (2022-2028)


Emphasis on Product (Cell Therapy, Gene Therapy, Tissue Engineering, And Small Molecule and Biologics); Material Type (Synthetic Materials, Biologically Derived Materials, Genetically Engineered Materials and Others); Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Immunology And Inflammation, Ophthalmology, Neurology, and Others); and Region/Country.







Report ID:



  Get a Sample
Report Description
Table of content
Research Methodology

Report Description

Regenerative Medicine Market
Regenerative Medicine Market

Global Regenerative Medicine Market is expected to grow at a significant rate of around 17.5% during the forecast period (2022-2028).  Regenerative medicine refers to a group of biomedical approaches to clinical therapies that may involve the use of stem cells. The market of regenerative medicine market is anticipated to grow enormously owing to factors such as the growing prevalence of genetic disorders and chronic diseases, the rising pipeline of the regenerative medicine products, and technological advancements in the regenerative medicine field. Increasing the adoption of stem cell technologies, gene therapies, and tissue engineering for treating conditions such as blood cancer and other hematologic conditions is driving the industry’s growth.  Moreover, the companies are also adopting strategic alliances to maintain a strategic edge in the global market. For instance, in July 2021, Pharming Group N.V. and Orchard Therapeutics collaborated for the development and commercialization of OTL-105, an investigational ex vivo autologous Hematopoietic Stem Cell (HSC) gene therapy for the treatment of Hereditary Angioedema (HAE).

Athersys, Inc., Corline Biomedical AB, Mesoblast, Nuvasive, Inc., Cook Biotech, Integra LifeSciences Corporation, Organogenesis, Osiris Therapeutics, Inc., Stryker Corporation, and U.S. Stem Cell, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst product, gene therapy category to witness higher CAGR during the forecast period”

Based on the product, the market is segmented into cell therapy, gene therapy, tissue engineering, and small molecule and biologics. The gene therapy segment is expected to grow with high CAGR during the forecast period owing to its benefits over conventional treatment options for the management of rare diseases. Moreover, rising companies’ investment is also driving the growth of the segment during the forecast period. For instance, in January 2023, Asklepios BioPharmaceutical, Inc. entered into collaboration with ReCode Therapeutics to explore single vector gene editing platform.

Regenerative Medicine Oil Market Report Coverage

Regenerative Medicine Market
Regenerative Medicine Market

“Amongst material type, the biological category to witness higher CAGR during the forecast period”

Based on material type, the global regenerative medicine market is segmented into synthetic materials, biologically derived materials, genetically engineered materials and others (pharmaceuticals). The biologically derived materials occupied the largest share and are expected to maintain its dominance throughout the forecast period (2022-2028) owing to the increased usage and advancements in biologically derived materials. Today, naturally derived biomaterials have been attracting scientist’s interest all over the world. Naturally derived biomaterial can be classified into many groups including protein-based biomaterials (collagen, gelatin, silk), polysaccharide-based biomaterials (cellulose, chitin/chitosan, glucose) and decellularized tissue-derived biomaterials (decellularized heart valves, blood vessels, liver). Naturally derived biomaterials have the advantages of immunomodulating, anti-toxic and biomimetic properties with the cellular environment in vivo when compared to synthetic biomaterials.

“Amongst application, oncology segment held a dominant share in the market in 2021”

On the basis of application, the market is segmented into cardiovascular, oncology, dermatology, musculoskeletal, immunology and inflammation, ophthalmology, neurology, and others. The oncology segment held a dominant share in the market in 2021. According to GLOBOCAN, in 2020, there were about 19.3 million new cancer cases and approximately 10 million deaths. Thus, the surge in the incidences of cancer is expected to foster the growth of the market. Moreover, rapid product approval and continuous advancement is also driving the segment growth. For instance, in May 2022, U.S. FDA approved Kymriah CAR T-cell therapy for the management of adult patients with relapsed or refractory follicular lymphoma.

“North America to hold a significant share in the market”

In 2020, North America held a significant share of the global regenerative medicine market, which is due to several factors, including the presence of major key players in the region, the surge in the geriatric population and the subsequent increase in the prevalence of cancer, highly developed healthcare system, the higher adoption of technically advanced products, and favorable government policies for the launch of advanced products. Moreover, rising company investment is also having a positive impact on the market’s growth of the market. For instance, in January 2022, Century Therapeutics entered into collaboration with Bristol Myers Squibb to develop and commercialize up to four induced pluripotent stem cell (“iPSC”) derived, engineered natural killer cell (“iNK”) and / or T cell (“iT”) programs for hematologic malignancies and solid tumors.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.

Customization Options:

The global regenerative medicine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Main Objective
2.1.Research Process of the Regenerative Medicine Market
2.2.Research Methodology of the Regenerative Medicine Market
2.3.Respondent Profile  
7.1.Cell Therapy 
7.2.Gene Therapy 
7.3.Tissue Engineering 
7.4.Small Molecules and Biologics
8.1.Synthetic Material 
8.2.Biologically Derived Materials
8.3.Genetically Engineered Materials
8.4.Others (Pharmaceuticals)
9.5.Immunology and Inflammation
10.1.North America  
 10.1.3.Rest of North America
 10.2.6.Rest of Europe
 10.3.4.Rest of Asia-Pacific
11.1.Market Drivers
11.2.Market Challenges
14.1.Demand Side Analysis
14.2.Supply Side Analysis
16.1.Competitive Landscape 
 16.1.1.Porters Fiver Forces Analysis
17.1.Athersys, Inc
17.2.Corline Biomedical AB
17.4.NuVasive, Inc.
17.5.Cook Biotech
17.6.Integra LifeSciences
17.8.Osiris Therapeutics, Inc
17.9.Stryker Corporation
17.10.U.S. Stem Cell Inc.

Research Methodology

Research Methodology for the Regenerative Medicine Market Analysis (2022-2028)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global regenerative medicine market were the three major steps undertaken to create and analyze the adoption of regenerative medicine in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global regenerative medicine market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the regenerative medicine market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the regenerative medicine market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product, material type, and application. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the regenerative medicine market. Further, we conducted factor analysis using dependent and independent variables such as various product, material type, and application of regenerative medicine. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the regenerative medicine market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global regenerative medicine market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of revenue (USD) and the adoption rate of the regenerative medicine market across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the global regenerative medicine market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions`

Regenerative Medicine Market
Regenerative Medicine Market

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global regenerative medicine market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, material type, and application in the global regenerative medicine market.

The main objective of the Global Regenerative Medicine Market Study

The current & future market trends of the global regenerative medicine market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the regenerative medicine market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of product, material type, and application.
  • Define and analysis of the regulatory framework for the regenerative medicine industry.
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
  • Analyze the current and forecast market size of the regenerative medicine market for the major region.
  • Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
  • Company profiles of the regenerative medicine market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?